Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Tuesday 14 June 2022, at which the following resolutions were made.
Legal Press releases
Stockholm, May 31, 2022 - Intervacc announces today that Strangvac®, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.
The period in summary
First quarter January 1 – March 31, 2022
- On March 23 the first batch of Strangvac ... Read more
Stockholm, May 19, 2022 - Intervacc AB (publ) announces the initiation of a proof-of-concept study to measure the effectiveness of a vaccine to protect dairy cows against mastitis caused by Staphylococcus ... Read more
The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Tuesday 14 June 2022 at 5.00 p.m. at Good Morning Hotel, ... Read more